Euromedis Groupe (ALEMG.PA)
EUR 4.45
(0.23%)
EUR 4.45
(0.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.01 Million EUR | -21.97% |
| 2022 | 12.83 Million EUR | -17.33% |
| 2021 | 15.52 Million EUR | -12.54% |
| 2020 | 17.75 Million EUR | -23.91% |
| 2019 | 23.33 Million EUR | 59.02% |
| 2018 | 14.67 Million EUR | 51.81% |
| 2017 | 9.66 Million EUR | 1.21% |
| 2016 | 9.55 Million EUR | -2.26% |
| 2015 | 9.77 Million EUR | -9.36% |
| 2014 | 10.78 Million EUR | -8.12% |
| 2013 | 11.73 Million EUR | 0.0% |
| 2012 | - EUR | -100.0% |
| 2011 | 5.93 Million EUR | -3.35% |
| 2010 | 6.14 Million EUR | 25.54% |
| 2009 | 4.89 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 9.03 Million EUR | 0.0% |
| 2023 Q4 | 10.01 Million EUR | 0.0% |
| 2023 Q3 | 10.01 Million EUR | -15.1% |
| 2023 Q2 | 11.79 Million EUR | 0.05% |
| 2023 Q1 | 11.79 Million EUR | -8.14% |
| 2023 FY | 10.01 Million EUR | -21.97% |
| 2022 FY | 12.83 Million EUR | -17.33% |
| 2022 Q3 | 12.83 Million EUR | -7.58% |
| 2022 Q2 | 13.89 Million EUR | -0.45% |
| 2022 Q1 | 13.95 Million EUR | -10.14% |
| 2022 Q4 | 12.83 Million EUR | 0.0% |
| 2021 Q1 | 16.63 Million EUR | -6.32% |
| 2021 FY | 15.52 Million EUR | -12.54% |
| 2021 Q3 | 15.53 Million EUR | -6.63% |
| 2021 Q2 | 16.63 Million EUR | 0.01% |
| 2021 Q4 | 15.52 Million EUR | -0.01% |
| 2020 Q3 | 17.75 Million EUR | -8.41% |
| 2020 Q1 | 19.38 Million EUR | -16.93% |
| 2020 FY | 17.75 Million EUR | -23.91% |
| 2020 Q2 | 19.38 Million EUR | 0.01% |
| 2020 Q4 | 17.75 Million EUR | 0.0% |
| 2019 Q2 | 17.59 Million EUR | 6.29% |
| 2019 Q4 | 23.33 Million EUR | 16.57% |
| 2019 Q3 | 20.01 Million EUR | 13.78% |
| 2019 FY | 23.33 Million EUR | 59.02% |
| 2019 Q1 | 16.55 Million EUR | 0.0% |
| 2018 FY | 14.67 Million EUR | 51.81% |
| 2017 Q1 | 10.96 Million EUR | 9.65% |
| 2017 FY | 9.66 Million EUR | 1.21% |
| 2017 Q4 | 11.91 Million EUR | -5.01% |
| 2017 Q3 | 12.54 Million EUR | 29.8% |
| 2017 Q2 | 9.66 Million EUR | -11.84% |
| 2016 FY | 9.55 Million EUR | -2.26% |
| 2016 Q4 | 9.99 Million EUR | 5.24% |
| 2016 Q1 | 9.01 Million EUR | -8.52% |
| 2016 Q2 | 9.55 Million EUR | 5.95% |
| 2016 Q3 | 9.5 Million EUR | -0.51% |
| 2015 FY | 9.77 Million EUR | -9.36% |
| 2015 Q2 | 9.77 Million EUR | 5.75% |
| 2015 Q1 | 9.24 Million EUR | -26.75% |
| 2015 Q4 | 9.85 Million EUR | 5.04% |
| 2015 Q3 | 9.38 Million EUR | -4.0% |
| 2014 Q4 | 12.61 Million EUR | 4.37% |
| 2014 FY | 10.78 Million EUR | -8.12% |
| 2014 Q2 | 10.78 Million EUR | 9.51% |
| 2014 Q1 | 9.84 Million EUR | -14.3% |
| 2014 Q3 | 12.08 Million EUR | 12.12% |
| 2013 Q2 | 11.73 Million EUR | 0.0% |
| 2013 Q3 | 11.16 Million EUR | -4.86% |
| 2013 Q4 | 11.48 Million EUR | 2.9% |
| 2013 Q1 | 11.73 Million EUR | -13.32% |
| 2013 FY | 11.73 Million EUR | 0.0% |
| 2012 Q1 | - EUR | 0.0% |
| 2012 Q4 | 13.53 Million EUR | 3.67% |
| 2012 Q3 | 13.05 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | - EUR | -100.0% |
| 2011 Q3 | - EUR | -100.0% |
| 2011 FY | 5.93 Million EUR | -3.35% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 Q2 | 5.93 Million EUR | 0.0% |
| 2010 Q2 | 6.14 Million EUR | 0.0% |
| 2010 Q4 | 2.41 Million EUR | 0.0% |
| 2010 FY | 6.14 Million EUR | 25.54% |
| 2009 FY | 4.89 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Affluent Medical SA | 17.13 Million EUR | 41.536% |
| Bluelinea Société Anonyme | 3.61 Million EUR | -176.762% |
| Carmat SA | 57.64 Million EUR | 82.624% |
| Diagnostic Medical Systems S.A. | 16.28 Million EUR | 38.488% |
| Eurobio Scientific Société anonyme | 100.63 Million EUR | 90.046% |
| Ikonisys S.A. | 3.2 Million EUR | -212.307% |
| Implanet S.A. | 6.15 Million EUR | -62.856% |
| Median Technologies SA | 23.01 Million EUR | 56.471% |
| SpineGuard SA | 3.08 Million EUR | -224.698% |
| Theraclion SA | 1.95 Million EUR | -413.511% |
| Euroapi S.A. | 225.5 Million EUR | 95.558% |
| Guerbet SA | 383.87 Million EUR | 97.39% |
| Ion Beam Applications SA | 41.58 Million EUR | 75.91% |
| Koninklijke Philips N.V. | 7.68 Billion EUR | 99.87% |
| Sequana Medical NV | 16.78 Million EUR | 40.327% |